These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30259757)

  • 1. Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics.
    Machado D; Azzali E; Couto I; Costantino G; Pieroni M; Viveiros M
    Future Microbiol; 2018 Sep; 13():1383-1402. PubMed ID: 30259757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
    Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
    PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphenylether-Modified 1,2-Diamines with Improved Drug Properties for Development against Mycobacterium tuberculosis.
    Foss MH; Pou S; Davidson PM; Dunaj JL; Winter RW; Pou S; Licon MH; Doh JK; Li Y; Kelly JX; Dodean RA; Koop DR; Riscoe MK; Purdy GE
    ACS Infect Dis; 2016 Jul; 2(7):500-8. PubMed ID: 27626102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A piperidinol-containing molecule is active against
    Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
    J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 2-aminothiazole-thiazolidinone conjugates as potential antitubercular agents.
    Abo-Ashour MF; Eldehna WM; George RF; Abdel-Aziz MM; Elaasser MM; Abou-Seri SM; Abdel Gawad NM
    Future Med Chem; 2018 Jun; 10(12):1405-1419. PubMed ID: 29788758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis.
    Karale UB; Krishna VS; Krishna EV; Choudhari AS; Shukla M; Gaikwad VR; Mahizhaveni B; Chopra S; Misra S; Sarkar D; Sriram D; Dusthackeer VNA; Rode HB
    Eur J Med Chem; 2019 Sep; 178():315-328. PubMed ID: 31195172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
    Bonnett SA; Dennison D; Files M; Bajpai A; Parish T
    PLoS One; 2018; 13(10):e0198059. PubMed ID: 30332412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
    Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
    ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, and Evaluation of Novel Hybrid Efflux Pump Inhibitors for Use against Mycobacterium tuberculosis.
    Kumar M; Singh K; Naran K; Hamzabegovic F; Hoft DF; Warner DF; Ruminski P; Abate G; Chibale K
    ACS Infect Dis; 2016 Oct; 2(10):714-725. PubMed ID: 27737555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
    Singh S; Roy KK; Khan SR; Kashyap VK; Sharma A; Jaiswal S; Sharma SK; Krishnan MY; Chaturvedi V; Lal J; Sinha S; Dasgupta A; Srivastava R; Saxena AK
    Bioorg Med Chem; 2015 Feb; 23(4):742-52. PubMed ID: 25614114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents.
    Kesicki EA; Bailey MA; Ovechkina Y; Early JV; Alling T; Bowman J; Zuniga ES; Dalai S; Kumar N; Masquelin T; Hipskind PA; Odingo JO; Parish T
    PLoS One; 2016; 11(5):e0155209. PubMed ID: 27171280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered drug efflux under iron deprivation unveils abrogated MmpL3 driven mycolic acid transport and fluidity in mycobacteria.
    Pal R; Hameed S; Fatima Z
    Biometals; 2019 Feb; 32(1):49-63. PubMed ID: 30430296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance.
    de Carvalho LP; Lin G; Jiang X; Nathan C
    J Med Chem; 2009 Oct; 52(19):5789-92. PubMed ID: 19736929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel acetohydroxyacid synthase inhibitors as active agents against Mycobacterium tuberculosis by virtual screening and bioassay.
    Wang D; Zhu X; Cui C; Dong M; Jiang H; Li Z; Liu Z; Zhu W; Wang JG
    J Chem Inf Model; 2013 Feb; 53(2):343-53. PubMed ID: 23316686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiology. TB--a new target, a new drug.
    Cole ST; Alzari PM
    Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development.
    Bailo R; Bhatt A; Aínsa JA
    Biochem Pharmacol; 2015 Aug; 96(3):159-67. PubMed ID: 25986884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.